Aurelia Private Equity logo

Aurelia Private Equity

Europe, Hessen, Germany, Frankfurt

Description

Aurelia Private Equity is focused on investments in early-stage technology companies in Germany.

Investor Profile

Aurelia Private Equity has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series A rounds (top funding stages).
  • Majority of deals are located in Germany, Singapore.
  • Strong thematic focus on Biotechnology, 3D Technology, Apps.

Stage Focus

  • Series C (60%)
  • Series B (20%)
  • Series A (20%)

Country Focus

  • Germany (80%)
  • Singapore (20%)

Industry Focus

  • Biotechnology
  • 3d Technology
  • Apps
  • Communities
  • Digital Entertainment
  • Messaging
  • Music
  • Social Network
  • Virtual World
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Aurelia Private Equity frequently co-invest with?

HP
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 1
BC Brandenburg Capital
Europe, Brandenburg, Germany, Potsdam
Co-Investments: 2
3i Group
Europe, England, United Kingdom, London
Co-Investments: 1
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 1
Aravis Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Rosetta Capital
Europe, England, United Kingdom, London
Co-Investments: 1
Brandenburg Kapital
Europe, Brandenburg, Germany, Potsdam
Co-Investments: 1
Generis Capital Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
EDBI
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Innoven Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1

What are some of recent deals done by Aurelia Private Equity?

GILUPI

Potsdam, Brandenburg, Germany

GILUPI is a Germany-based company that develops medical devices for the in vivo isolation of rare cells out of circulating blood.

BiotechnologyHealth CareMedicalMedical Device
Series CJan 13, 2011
Amount Raised: $4,798,260
Club Cooee

Kaiserslautern, Rheinland-Pfalz, Germany

Club Cooee is a 3D social network where millions of users from all over the world meet and connect in user-generated rooms.

3D TechnologyAppsCommunitiesDigital EntertainmentMessagingMusicSocial NetworkVirtual World
Series BOct 27, 2010
MerLion Pharma

Singapore, Central Region, Singapore

MerLion Pharmaceuticals is a drug discovery and development company that researches and develops natural products.

BiotechnologyPharmaceutical
Series COct 11, 2010
Amount Raised: $7,000,000
Club Cooee

Kaiserslautern, Rheinland-Pfalz, Germany

Club Cooee is a 3D social network where millions of users from all over the world meet and connect in user-generated rooms.

3D TechnologyAppsCommunitiesDigital EntertainmentMessagingMusicSocial NetworkVirtual World
Series AOct 20, 2007
Combinature Biopharm

Berlin, Berlin, Germany

Combinature Biopharm is a drug discovery and development company.

Biotechnology
Series CMay 8, 2006
Amount Raised: $5,110,000

Find More Investors Like Aurelia Private Equity

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Aurelia Private Equity | Pipeseed